Ventyx Biosciences, Inc. (VTYX)
USD 2.3
(-2.95%)
USD 2.3
(-2.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -166.52 Million | -98.77 Million | -38.65 Million | -6.19 Million | -2.64 Million |
| Net Income | -192.96 Million | -108.42 Million | -83.74 Million | -28.17 Million | -4.32 Million |
| Depreciation & Amortization | 941 Thousand | 470 Thousand | 30 Thousand | - | - |
| Deferred income taxes | 745 Thousand | - | - | - | - |
| Stock-based compensation | 28.58 Million | 16.57 Million | 2.73 Million | 45 Thousand | 198 Thousand |
| Change in working capital | 5.8 Million | -5.15 Million | 4.01 Million | 812 Thousand | 591 Thousand |
| Other non-cash items | -9.64 Million | -2.22 Million | 38.32 Million | 21.12 Million | 896 Thousand |
| Investing Cash Flow | 100.94 Million | -74.93 Million | -214.36 Million | - | - |
| Investments in PPE | -514 Thousand | -275 Thousand | -262 Thousand | - | - |
| Acquisitions | -101.45 Thousand | 74.65 Thousand | 1.89 Million | - | - |
| Investment purchases | -272.27 Million | -347.23 Million | -232.5 Million | - | - |
| Sales/Maturities of investments | 373.72 Million | 272.58 Million | 16.5 Million | - | - |
| Other Investing Activities | 101.45 Thousand | -74.65 Thousand | -216 Thousand | - | - |
| Financing Cash Flow | 53.32 Million | 167.77 Million | 323.55 Million | 6.13 Million | 2.95 Million |
| Debt repayment | - | - | -450 Thousand | -6.12 Million | -2.95 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | 250 Thousand | 267 Thousand | - | - | - |
| Common Stock Issuance | 53.32 Million | 167.77 Million | 158.81 Million | 2000.00 | 1000.00 |
| Other Financing Activities | 53.32 Million | 167.77 Million | 165.18 Million | 12.25 Million | 5.9 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -745 Thousand | 1.61 Million | 2.44 Million | 591 Thousand | 361 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 745 Thousand | -6.77 Million | 1.57 Million | 221 Thousand | 230 Thousand |
| Cash at beginning of period | 64.81 Million | 70.79 Million | 244 Thousand | 309 Thousand | - |
| Cash at end of period | 52.55 Million | 64.81 Million | 70.79 Million | 244 Thousand | 309 Thousand |
| Capital Expenditure | -514 Thousand | -275 Thousand | -262 Thousand | - | - |
| Effect of forex changes on cash | -12 Thousand | -42 Thousand | 11 Thousand | - | - |
| Net cash flow / Change in cash | -12.26 Million | -5.97 Million | 70.54 Million | -65 Thousand | 309 Thousand |
| Free Cash Flow | -167.03 Million | -99.04 Million | -38.91 Million | -6.19 Million | -2.64 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -31.95 Million | -38.57 Million | -192.96 Million | -46.75 Million | -54.02 Million | -53.25 Million |
| Depreciation & Amortization | 316 Thousand | 408 Thousand | 941 Thousand | 403 Thousand | 265 Thousand | 139 Thousand |
| Deferred income taxes | - | - | 745 Thousand | -10.53 Million | - | - |
| Stock-based compensation | 5.77 Million | 6.54 Million | 28.58 Million | 6.14 Million | 8 Million | 7.86 Million |
| Change in working capital | 4.07 Million | -13.97 Million | 5.8 Million | -9.25 Million | 13.22 Million | -1.54 Million |
| Other non-cash items | 1.63 Million | 6.51 Million | -9.64 Million | 8.34 Million | -2.13 Million | -2.49 Million |
| Investing Cash Flow | -75.52 Million | 41.76 Million | 100.94 Million | 46.12 Million | 38.89 Million | 34.81 Million |
| Investments in PPE | -60 Thousand | -175 Thousand | -514 Thousand | -211 Thousand | -48 Thousand | -195 Thousand |
| Acquisitions | - | - | -101.45 Thousand | -46.33 Thousand | -38.93 Thousand | -35.01 Thousand |
| Investment purchases | -150.71 Million | -25.45 Million | -272.27 Million | -28.66 Million | -70.78 Million | -63.98 Million |
| Sales/Maturities of investments | 75.25 Million | 67.39 Million | 373.72 Million | 75 Million | 109.72 Million | 99 Million |
| Other Investing Activities | -75.46 Million | 41.94 Million | 101.45 Thousand | 46.33 Thousand | 38.93 Thousand | 35.01 Thousand |
| Financing Cash Flow | -906 Thousand | 96.18 Million | 53.32 Million | 585 Thousand | 1.62 Million | 2.47 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -906 Thousand | - | 250 Thousand | 250 Thousand | - | - |
| Common Stock Issuance | -906 Thousand | 96.18 Million | 53.32 Million | 585 Thousand | 1.62 Million | 2.47 Million |
| Other Financing Activities | 140 Thousand | 92 Thousand | 53.32 Million | 585 Thousand | 1.62 Million | 2.47 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 2.01 Million | -1.19 Million | -745 Thousand | -3.58 Million | 5.21 Million | -2.28 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.05 Million | -12.78 Million | 745 Thousand | -5.67 Million | 8.01 Million | 733 Thousand |
| Cash at beginning of period | 141.89 Million | 51.57 Million | 64.81 Million | 56.61 Million | 51.71 Million | 63.66 Million |
| Cash at end of period | 40.92 Million | 141.89 Million | 52.55 Million | 51.57 Million | 57.58 Million | 51.71 Million |
| Capital Expenditure | -60 Thousand | -175 Thousand | -514 Thousand | -211 Thousand | -48 Thousand | -195 Thousand |
| Effect of forex changes on cash | -9000.00 | -5000.00 | -12 Thousand | -86 Thousand | 16 Thousand | 38 Thousand |
| Net cash flow / Change in cash | -100.97 Million | 90.31 Million | -12.26 Million | -5.03 Million | 5.86 Million | -11.95 Million |
| Free Cash Flow | -24.59 Million | -47.8 Million | -167.03 Million | -51.86 Million | -34.71 Million | -49.47 Million |
NXTT
CCC
IAS
CBA
JDEP
NX